Hemorrhoids Treatment Market is experiencing constant growth owing to growing number of people suffering from anorectal conditions, growing awareness about treatments, and developments in minimal invasive techniques. Piles, or hemorrhoids, are prevalent in the world population due to various reasons, such as obesity, physical inactivity, constipation, and age-related health issues. The increasing trend towards convenient treatment methods, such as topical drugs, oral drugs, and outpatient surgery, is propelling the market.
Hemorrhoids Treatment Market size was valued at USD 1.13 billion in 2024 and is forecasted to grow to USD 1.82 billion by 2032, with a CAGR of 6.15% in the period between 2025 and 2032. Market growth is mainly driven by factors such as an increase in the use of OTC drugs, advancements in the formulation of topical medicines, and developments in procedures including infrared coagulation, rubber band ligation, and radiofrequency procedures. Other factors contributing to the growth of the market include increased healthcare expenditure and healthcare accessibility.
Gain More Information on Hemorrhoids Treatment Market – Request Free Sample Report
Top 4 Hemorrhoids Treatment Companies
1. Church & Dwight Co.
Church & Dwight Company is positioning itself in the consumer healthcare category through the range of products it offers to treat hemorrhoids. Church & Dwight’s main focus is on providing easily accessible OTC treatments that help treat problems such as pain, irritation and inflammation caused by hemorrhoids. The company announced in April 2024 the introduction of a new hemorrhoid cream product with dual functionality to treat both pain and inflammation. This is in line with the company’s expansion strategy in the gastrointestinal healthcare market. There is a rising trend among consumers to opt for OTC products.
2. Sebela Pharmaceuticals
Sebela Pharmaceuticals is a specialty pharmaceutical firm that specializes in therapies for gastrointestinal disorders and other segments in the healthcare industry. The company has contributed to the market for treatment of hemorrhoids through developments in rectal therapies and pharmaceuticals aimed at improving the condition of patients. Sebela Pharmaceuticals has broadened the indications of rectal therapies in order to facilitate the development of more effective approaches to the treatment of anorectal disorders.
3. Boston Scientific Corporation
Boston Scientific is one of the world’s leading developers and manufacturers of medical devices and provides minimally invasive solutions in different therapeutic categories. Boston Scientific is currently working on evolving the current methods of treating hemorrhoids through new technologies that help reduce recovery time and increase patient satisfaction. In January 2024, Boston Scientific announced the start of the clinical trials of a minimally invasive technology that will be used to eliminate internal hemorrhoids.
4. Abbott
Abbott is one of the major multinational companies operating in the health care sector. Abbott continues investing in medical innovation and health care technologies in line with the increasing need for treatment solutions for anorectal conditions that are more efficient and patient-friendly. Abbott's robust health care network and the company's investment in medical innovations make it a key player in the hemorrhoids treatment market. Minimally invasive procedure trends and the rising demand for treatment solutions will provide new business opportunities for Abbott in the health care market.
What is Driving the Future of the Hemorrhoids Treatment Market?
Increasing occurrence of constipation, obesity, unhealthiness in diets, and inactive lifestyle continues to be one of the key drivers behind the demand for hemorrhoids treatments. A large number of people suffer from hemorrhoids throughout their lives, thus ensuring an ever-present demand for efficient treatments. Technological innovations in the field of treatment are revolutionizing the hemorrhoids market too. Non-invasive techniques like rubber band ligation, infrared coagulation, and sclerotherapy have become more popular because of shorter recovery periods and lesser pain in comparison with the invasive technique of surgery.
The growing use of topically applied as well as orally administered medications is adding to market growth as well. There is widespread preference for creams, ointments, suppositories, and orally ingested pain killers because of their cost-effectiveness, availability, and use in early stages of hemorrhoids. Efforts are being made by companies to develop more effective medications that are safe.
Regional Analysis of the Hemorrhoids Treatment Market
The North American region held a prominent position in the worldwide hemorrhoids treatment market in 2024 owing to the development of healthcare facilities and knowledge about the anorectal diseases along with the presence of large-scale players in the pharmaceutical and medical devices industry. The U.S. holds its significance due to high requirements for minimal intervention procedures, advanced treatment options, and highly developed health care facilities.
The Asia Pacific region is forecasted to emerge as the fastest-growing region owing to the rise in number of patients, improvement in healthcare access, urbanization, and use of over-the-counter healthcare products. China still continues to be a major contributor because of its aging population and increased spending on healthcare. There has been an increase in the demand for healthcare in India owing to increased awareness and generic availability.
The Road Ahead
The future of the Hemorrhoids Treatment Market is expected to be driven by rising use of minimally invasive techniques, advancements in technology for medical devices and innovations in drug formulations. Enhanced healthcare awareness, enhanced diagnostic abilities and development in digital healthcare solutions will further enhance patients' accessibility to such advanced treatment solutions. Moreover, increasing emphasis on disease management and personalized healthcare solutions will aid market development and treatment outcomes.
Businesses that concentrate on topical therapies, outpatient procedures and patient-friendly solutions are projected to acquire competitive edge as more healthcare facilities are moving towards treatment methods which are both cost-effective and minimally-invasive. The increasing rate of diseases, enhanced diagnostic capability and continuous product innovation will contribute to future growth until 2032.
